A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Alogliptin Compared with Placebo in Pediatric Subjects With Type 2 Diabetes Mellitus
|Effective start/end date
|5/1/18 → 10/31/22
- THE EMMES CORPORATION
- TAKEDA DEVELOPMENT CENTER AMERICAS, INC.
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.